Adjuvant chemoradiation for pancreatic adenocarcinoma: The johns hopkins hospital-mayo clinic collaborative study

Annals of Surgical Oncology

Volumn 17, Issue 4, 2010, Pages 981-990

  Hsu, Charles C ^a,d   Herman, Joseph M ^a   Corsini, Michele M ^b   Winter, Jordan M ^a   Callister, Matthew D ^c   Haddock, Michael G ^b   Cameron, John L ^a   Pawlik, Timothy M ^a   Schulick, Richard D ^a   Wolfgang, Christopher L ^a   Laheru, Daniel A ^a   Farnell, Michael B ^b   Swartz, Michael J ^a   Gunderson, Leonard L ^c   Miller, Robert C ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952090720     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0743-7     Document Type: Article

References (32)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun, et al. 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 49 10.3322/caac.20006 19474385
2. JL Cameron TS Riall J Coleman KA Belcher 2006 One thousand consecutive pancreaticoduodenectomies Ann Surg. 244 10 15 10.1097/01.sla.0000217673.04165.ea 16794383 (Pubitemid 43905176)
3. JE Lim MW Chien CC Earle 2003 Prognostic factors following curative resection for pancreatic adenocarcinoma: A population-based, linked database analysis of 396 patients Ann Surg. 237 74 85 10.1097/00000658-200301000-00011 12496533 (Pubitemid 36622320)
4. M Trede G Schwall HD Saeger 1990 Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality Ann Surg 211 447 458 10.1097/00000658-199004000-00011 1:STN:280:DyaK3c3htVOgug%3D%3D 2322039 (Pubitemid 20138186)
5. RJ Geer MF Brennan 1993 Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg. 165 68 72 10.1016/S0002- 9610(05)80406-4 1:STN:280:DyaK3s7hvVynsQ%3D%3D 8380315
6. DW Crist JV Sitzmann JL Cameron 1987 Improved hospital morbidity, mortality, and survival after the Whipple procedure Ann Surg. 206 358 365 10.1097/00000658-198709000-00014 1:STN:280:DyaL2szisFWksw%3D%3D 3632096
7. ML Foo LL Gunderson DM Nagorney DC McLlrath JA van Heerden JS Robinow, et al. 1993 Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil Int J Radiat Oncol Biol Phys. 26 483 489 1:STN:280:DyaK3s3ptlGltg%3D%3D 8390422
8. MH Kalser SS Ellenberg 1985 Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg. 120 899 903 1:STN:280:DyaL2M3ltFSnsQ%3D%3D 4015380 (Pubitemid 15040883)
9. JH Klinkenbijl J Jeekel T Sahmoud R van Pel ML Couvreur CH Veenhof, et al. 1999 Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg. 230 776 782 10.1097/00000658-199912000-00006 1:STN:280:DC%2BD3c%2FotFKkug%3D%3D 10615932 (Pubitemid 30191812)
10. MC Garofalo WF Regine MT Tan 2006 On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer Ann Surg. 244 332 333 10.1097/01.sla.0000229980.81505.44 16858208 (Pubitemid 44305560)
11. JP Neoptolemos DD Stocken H Friess C Bassi JA Dunn H Hickey, et al. 2004 A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med. 350 1200 1210 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D 15028824 (Pubitemid 38339364)
12. JP Neoptolemos JA Dunn DD Stocken J Almond K Link H Beger, et al. 2001 Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial Lancet. 358 1576 1585 10.1016/S0140-6736(01)06651-X 1:CAS:528:DC%2BD3MXosFKmtro%3D 11716884 (Pubitemid 33101907)
13. M Garofalo T Flannery W Regine 2006 The case for adjuvant chemoradiation for pancreatic cancer Best Pract Res Clin Gastroenterol. 20 403 416 10.1016/j.bpg.2005.11.001 1:CAS:528:DC%2BD28Xis1Srtb0%3D 16549335
14. MC Koshy JC Landry SX Cavanaugh CD Fuller CG Willett RA Abrams, et al. 2005 A challenge to the therapeutic nihilism of ESPAC-1 Int J Radiat Oncol Biol Phys. 61 965 966 15752874
15. Crane CH, Ben-Josef E, Small W, Jr., Morris SL, Beasley M, Leslie M, Bydder S, Spry N. Chemotherapy for pancreatic cancer. N Engl J Med. 2004;350:2713-5.
16. RA Abrams KD Lillemoe S Piantadosi 2001 Continuing controversy over adjuvant therapy of pancreatic cancer Lancet. 358 1565 1566 10.1016/S0140- 6736(01)06666-1 1:STN:280:DC%2BD3MnntFKmtQ%3D%3D 11716876 (Pubitemid 33101899)
17. DB Evans KR Hess PW Pisters 2002 ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas Ann Surg. 236 694 696 10.1097/00000658-200211000-00023 12409677
18. MA Choti 2004 Adjuvant therapy for pancreatic cancer-the debate continues N Engl J Med. 350 1249 1251 10.1056/NEJMe048002 1:CAS:528:DC%2BD2cXit12rt7k%3D 15028829 (Pubitemid 38339369)
19. JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann, et al. 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med. 345 725 730 10.1056/NEJMoa010187 1:STN:280:DC%2BD3Mvps1Cqug%3D%3D 11547741
20. E Kapiteijn CA Marijnen ID Nagtegaal H Putter WH Steup T Wiggers, et al. 2001 Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med. 345 638 646 10.1056/NEJMoa010580 1:STN:280:DC%2BD3Mvps1ektw%3D%3D 11547717 (Pubitemid 34066236)
21. CJ Yeo RA Abrams LB Grochow TA Sohn SE Ord RH Hruban, et al. 1997 Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg. 225 621 633 10.1097/00000658-199705000-00018 1:STN:280: DyaK2szjs1Cgug%3D%3D 9193189 (Pubitemid 28079110)
22. MM Corsini RC Miller MG Haddock JH Donohue MB Farnell DM Nagorney, et al. 2008 Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005) J Clin Oncol. 26 3511 3516 10.1200/JCO.2007.15. 8782 18640932
23. JM Herman MJ Swartz CC Hsu J Winter TM Pawlik E Sugar, et al. 2008 Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital J Clin Oncol. 26 3503 3510 10.1200/JCO.2007.15.8469 18640931
24. WF Regine KA Winter RA Abrams H Safran JP Hoffman A Konski, et al. 2008 Fluorouracil vs. gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA. 299 1019 1026 10.1001/jama.299.9.1019 1:CAS:528:DC%2BD1cXjtVSltL0%3D 18319412 (Pubitemid 351347058)
25. BC Reeves 2008 Principles of research: limitations of non-randomized studies Surgery (Oxford) 26 120 124 10.1016/j.mpsur.2008.02.004 (Pubitemid 351459379)
26. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer-Verlag; 2003.
27. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall; 1984.
28. CD Newgard JR Hedges M Arthur RJ Mullins 2004 Advanced statistics: The propensity score-a method for estimating treatment effect in observational research Acad Emerg Med. 11 953 961 15347546 (Pubitemid 39149929)
29. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer. 1987;59:2006-10.
30. DB Evans GR Varadhachary CH Crane CC Sun JE Lee PW Pisters, et al. 2008 Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol. 26 3496 3502 10.1200/JCO.2007.15.8634 1:CAS:528:DC%2BD1cXpvVWmtLo%3D 18640930
31. GR Varadhachary RA Wolff CH Crane CC Sun JE Lee PW Pisters, et al. 2008 Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head J Clin Oncol. 26 3487 3495 10.1200/JCO.2007.15.8642 1:CAS:528:DC%2BD1cXpvVWmtL0%3D 18640929
32. H Oettle S Post P Neuhaus K Gellert J Langrehr K Ridwelski, et al. 2007 Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial JAMA. 297 267 277 10.1001/jama.297.3.267 1:CAS:528:DC%2BD2sXotVCmug%3D%3D 17227978 (Pubitemid 46143304)